Delivered-To: sometime5858@gmail.com
Received: by 10.31.163.216 with SMTP id m207csp202051vke;
        Thu, 15 Sep 2016 20:40:40 -0700 (PDT)
X-Received: by 10.55.143.134 with SMTP id r128mr13949853qkd.161.1473997240656;
        Thu, 15 Sep 2016 20:40:40 -0700 (PDT)
Return-Path: <T.Cu@nucleusnetwork.com.au>
Received: from mail1.bemta8.messagelabs.com (mail1.bemta8.messagelabs.com. [216.82.243.194])
        by mx.google.com with ESMTPS id q22si1431147qkh.81.2016.09.15.20.40.08
        (version=TLS1_2 cipher=ECDHE-RSA-AES128-GCM-SHA256 bits=128/128);
        Thu, 15 Sep 2016 20:40:40 -0700 (PDT)
Received-SPF: neutral (google.com: 216.82.243.194 is neither permitted nor denied by best guess record for domain of t.cu@nucleusnetwork.com.au) client-ip=216.82.243.194;
Authentication-Results: mx.google.com;
       spf=neutral (google.com: 216.82.243.194 is neither permitted nor denied by best guess record for domain of t.cu@nucleusnetwork.com.au) smtp.mailfrom=T.Cu@nucleusnetwork.com.au
Return-Path: <T.Cu@nucleusnetwork.com.au>
Received: from [216.82.242.34] by server-2.bemta-8.messagelabs.com id 28/CE-26872-3996BD75; Fri, 16 Sep 2016 03:40:03 +0000
X-Brightmail-Tracker: H4sIAAAAAAAAA1WTf0yUdRzH+z4/T8bVI+j4Rlp51WoKKC7ax62
  5azX32HRps1iW1l09crcdB91ztqul3jqiuCZeB8hxahyQDo8f4gHzB4h4kwyK8eOSMwFLIS9+
  pScYISQ9DzeUvn9899rn/d77836256sgY4bZeIVgMQsmo8agYqKoVZP7vIlOfW/qmrHRWHB7+
  gmw5lyh4GK9l4aT7X0kNN20gHsgSEHOUAhBc8BPQ1WwCIGttJ6G02NeCqprrCTc80wimAkcYW
  D2q7M0XL/gZME7ZWPgxNfrIPzFBA3uv300dASP09D0Yx0Nf81Wk3C+qpYE5x/PQ89MIwUjztV
  w6M4wAdntr4PrUiEJecX/0FDTvxNmDm6Gmct2GlxFFRSErOUsFI3mI6gfCtKQ698vpdSkQE6d
  n4DpikMk3A9jaJ4OSK0HrlHQ33CVhrz2WgK67C0E9N22UeC+/jHYev8lIftSiIXmcCkFh//MR
  jBrfRaulRSxUDdRiyD35DL4pVAa/2r/HHKPNrHQWywFnmqVPnT8Sy9ST5B8WXk+zf+We1e6Go
  6zfMm9LoYfLfexvKNsluBzR75DfGjcQ/BZIzcYvrPuFM333DrL8kePVLD8GXc/y98O7+Rrx6c
  Ivsx3ntmi3k7rjdoMywe07kZ3M8osmEEWpyOftSJnCNnRIkUMdwDhpvK9MjPcShzcX8DKHMu9
  jM/ZsuZ4CfcKLvQPkXakkHgD7mtLkMcU9xyuqAzOWZTcJtxhvUzZUZQU6UD4p5IzjCws4jbjv
  O58QmbELcfTnb2kzCQXh68OFs/NMcfh7xs7yAgvxUMD9+kIq3C4eoyR95KcEX97d19k12LcWj
  RIORDnXpDkfuhyL3BFLAnY03CHifAqfKxkhJznn5sHiIVzD2K96AVRMH0imBKT1yZpTfo0nTl
  dozckJq+BpHRBFDVpgkGjFZM+zEj3Iem/f0Q6p5HD/aofPa4gVEuVn63oTY15VJvx0ac6jah7
  37TbIIh+tEyhUGFlOE3SFpuENMGyS2+QHs+8jBXRqiVKpU6SlWKmJl3Up0WkNpSoyJrsqSJiK
  GOGUYiPU66XTZxs0u02PoiYf4LdaHl8rBJJpWKiMwVTut78f30YxSmQKlb5ppwSrTeaH2walk
  oQUom6yqBcwqx5KMVbkaX1m9KMc7aUtrVV5eKVUddqtStlb+KLr13smXx3qNP7O5/5jM/cpY2
  qWF+2x7d1+x51yq7DntEq5zHDU66ByYA2DkW9cWLT4HtPFBa/lNrCOCrfeUx/S/3WxnXjmS2N
  CTuyOzf+cPPprV0HaOOUUHChZUf32xtc27bUTgTEbStCT3Y0qChRp0leSZpEzX/UFS9CfQQAA
  A==
X-Env-Sender: T.Cu@nucleusnetwork.com.au
X-Msg-Ref: server-8.tower-73.messagelabs.com!1473997198!51724420!1
X-Originating-IP: [43.247.127.170]
X-StarScan-Received:
X-StarScan-Version: 8.84; banners=nucleusnetwork.com.au,-,-
X-VirusChecked: Checked
Received: (qmail 84990 invoked from network); 16 Sep 2016 03:40:01 -0000
Received: from 170.127.247.43.static.as24516.net (HELO PRNEX2010.nucleus.local) (43.247.127.170)
  by server-8.tower-73.messagelabs.com with DHE-RSA-AES256-SHA encrypted SMTP; 16 Sep 2016 03:40:01 -0000
Received: from PRNEX2010.nucleus.local ([::1]) by PRNEX2010.nucleus.local
 ([::1]) with mapi id 14.02.0318.004; Fri, 16 Sep 2016 13:39:57 +1000
From: Tina Cu <T.Cu@nucleusnetwork.com.au>
Subject: DGAT - Quick study finished in 5 days + 1 follow up
Thread-Topic: DGAT - Quick study finished in 5 days + 1 follow up
Thread-Index: AdIPt4t7PzxoAU+oTLixpz9BXbDLSwAAeXQwAAB23SAAAJFuwAADkIww
Date: Fri, 16 Sep 2016 03:39:55 +0000
Message-ID: <FD1C4625A9476F49819B4449974CD12C1EC443@PRNEX2010.nucleus.local>
References: <FD776FCE5BFEC045840FAB11F4BAF354B651A924@PRNEX2010.nucleus.local>
 <FD1C4625A9476F49819B4449974CD12C1EB31F@PRNEX2010.nucleus.local>
In-Reply-To: <FD1C4625A9476F49819B4449974CD12C1EB31F@PRNEX2010.nucleus.local>
Accept-Language: en-AU, en-US
Content-Language: en-US
X-MS-Has-Attach:
X-MS-TNEF-Correlator:
x-originating-ip: [192.168.101.88]
Content-Type: multipart/alternative;
	boundary="_000_FD1C4625A9476F49819B4449974CD12C1EC443PRNEX2010nucleusl_"
MIME-Version: 1.0
X-TUID: p6/C+UKuDbQL

--_000_FD1C4625A9476F49819B4449974CD12C1EC443PRNEX2010nucleusl_
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

Hi,

Recruitment is now open for Group 8 of the popular DGAT Non-Alcoholic Fatt=
y Liver Disease study!

5 days/nights inpatient stay with just one follow up, screening beginning =
next week Monday 19 September. Get in quick guys as this study fills very =
quickly!


If you are interested in the study below, please respond to this email as =
we need to book you for a screening visit (medical check up).

Please note we call from a private number.



YOU NEED TO CALL/EMAIL TO MAKE AN APPOINTMENT. NO WALK-INS.

WHEN YOU CALL, QUOTE "DGAT STUDY"

Screening from Monday 19th September



204856: This study is investigating a drug that has been developed as a po=
tential treatment for Non-Alcoholic Fatty Liver Disease (NAFLD).

Fat build up in the liver is responsible for liver disease which affects b=
etween 9% and 37% of the population in different parts of the world and is=
 an increasing health burden to our society. In Australia, NAFLD is becomi=
ng an increasing problem in parallel with the growing epidemic of obesity.=
 The best treatment for NAFLD is diet and exercise, however too few people=
 can maintain lifestyle changes to maintain meaningful changes to their he=
alth. NAFLD can lead to the more severe form called Nonalcoholic Steatohep=
atitis (NASH) and ultimately to cirrhosis (scarring of liver), complete li=
ver failure, or cancer. Currently there are no effective available treatme=
nts for these conditions.

A central mediator in the transition from NAFLD to NASH is thought to be i=
ncreased fat in the form of triglycerides in the liver and other tissues. =
GSK3008356 works in a unique way by binding to and inhibiting a protein ca=
lled DGAT1 which is a key protein involved in making triglycerides. It is =
hoped that GSK3008356 could be a better treatment option for those sufferi=
ng from NAFLD and other related diseases.

Please click here for more information (Participant Information and Consen=
t Form)<http://clinicalstudies.com.au/wp-content/uploads/2016/09/PICF_v3_G=
SK-DGAT_Part-1_SD_15Aug2016.pdf>


 Volunteers required:

*         Healthy Males

*         Aged 18 - 65 years

*         BMI 19 - 25 (Minimum weight 50 kg)
Link to BMI calculator: http://halls.md/body-mass-index/av.htm

*         Not taking any medications

*         You need to be able to eat the set menu (it will contain dairy)

*         Not regular smokers and haven't smoked in the last week (there i=
s a nicotine test)


Study Duration

*           5 days/nights as an inpatient

*           1 outpatient visit


Our Location

Centre for Clinical Studies (AMREP Precinct Alfred Hospital) AMREP access =
map<http://clinicalstudies.com.au/wp-content/uploads/2014/02/AMREP-CCS-Acc=
ess-MAP.pdf>
Level 5, 89 Commercial Road,
Melbourne, 3004.
Click here<https://maps.google.com.au/maps?q=3D89+commercial+road+melbourn=
e+3004&ie=3DUTF-8&hq=3D&hnear=3D0x6ad66822902afed9:0xca1cf794638a5956,85-8=
9+Commercial+Rd,+Melbourne+VIC+3004&gl=3Dau&ei=3DrwD8UqTNL4GRkwX88YH4Aw&ve=
d=3D0CCYQ8gEwAA> for the Google map.

Reimbursement: $1,600

Study Schedule:
Cohort 8

Study Day

Date

Time

Comments

On Study

Day -2

Wednesday, 5 October 2016

14:00

Check-in

Day 4

Monday, 10 October 2016

Before 12:00

Check-out

Final Visit

Day 7

Thursday, 13 October 2016

1 hour

Outpatient


To view our Participant Information Brochure please click here<http://clin=
icalstudies.com.au/wp-content/uploads/2014/02/CCS-Volunteer-Brochure.pdf> =
and read more about our organisation and about clinical trials generally.

Please also visit our website at www.clinicalstudies.com.au<http://www.cli=
nicalstudies.com.au>

If you do not wish to receive any further emails from us then please reply=
 to this email with the word 'unsubscribe' in the subject box.


Thanking you again for your interest.

Kind Regards,
Tina Cu
Tina Cu| Recruitment Officer | CCS AMREP | Centre for Clinical Studies |
Office: | Level 5 Burnet Institute | AMREP Precinct | 89 Commercial Road |=
 Victoria 3004 | Australia
Mail: | PO Box 6083, St Kilda Road Central, Melbourne, 8008, Victoria, Aus=
tralia |
Telephone: | T: 1800 243 733 | T: 9076 8936
t.cu@nucleusnetwork.com.au<mailto:t.cu@nucleusnetwork.com.au>    www.clini=
calstudies.com<http://www.nucleusnetwork.com.au/>.au<http://www.nucleusnet=
work.com.au/>

Nucleus Network, Australia's Clinical Research Centre, operates in associa=
tion with Centre for Clinical Studies, Clinical Trials Consulting and its =
network partners.

You can now follow us on Facebook<https://www.facebook.com/pages/Centre-fo=
r-Clinical-Studies/199371513417842>
Please consider the environment before printing this e-mail

______________________________________________________________________
This email has been scanned by the Symantec Email Security.cloud service.
For more information please visit http://www.symanteccloud.com
______________________________________________________________________
--_000_FD1C4625A9476F49819B4449974CD12C1EC443PRNEX2010nucleusl_
Content-Type: text/html; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-mic=
rosoft-com:office:office" xmlns:w=3D"urn:schemas-microsoft-com:office:word=
" xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" xmlns=3D"ht=
tp://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dus-ascii=
">
<meta name=3D"Generator" content=3D"Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
=09{font-family:"Cambria Math";
=09panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
=09{font-family:Calibri;
=09panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
=09{font-family:Tahoma;
=09panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
=09{font-family:Consolas;
=09panose-1:2 11 6 9 2 2 4 3 2 4;}
@font-face
=09{font-family:Verdana;
=09panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
=09{font-family:"Edwardian Script ITC";
=09panose-1:3 3 3 2 4 7 7 13 8 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
=09{margin:0cm;
=09margin-bottom:.0001pt;
=09font-size:11.0pt;
=09font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
=09{mso-style-priority:99;
=09color:blue;
=09text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
=09{mso-style-priority:99;
=09color:purple;
=09text-decoration:underline;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
=09{mso-style-priority:99;
=09mso-style-link:"Plain Text Char";
=09margin:0cm;
=09margin-bottom:.0001pt;
=09font-size:10.5pt;
=09font-family:Consolas;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
=09{mso-style-priority:99;
=09mso-style-link:"Balloon Text Char";
=09margin:0cm;
=09margin-bottom:.0001pt;
=09font-size:8.0pt;
=09font-family:"Tahoma",sans-serif;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
=09{mso-style-priority:34;
=09margin-top:0cm;
=09margin-right:0cm;
=09margin-bottom:0cm;
=09margin-left:36.0pt;
=09margin-bottom:.0001pt;
=09font-size:11.0pt;
=09font-family:"Calibri",sans-serif;}
p.msonormal0, li.msonormal0, div.msonormal0
=09{mso-style-name:msonormal;
=09mso-margin-top-alt:auto;
=09margin-right:0cm;
=09mso-margin-bottom-alt:auto;
=09margin-left:0cm;
=09font-size:12.0pt;
=09font-family:"Times New Roman",serif;}
span.PlainTextChar
=09{mso-style-name:"Plain Text Char";
=09mso-style-priority:99;
=09mso-style-link:"Plain Text";
=09font-family:Consolas;}
span.BalloonTextChar
=09{mso-style-name:"Balloon Text Char";
=09mso-style-priority:99;
=09mso-style-link:"Balloon Text";
=09font-family:"Tahoma",sans-serif;}
p.Default, li.Default, div.Default
=09{mso-style-name:Default;
=09margin:0cm;
=09margin-bottom:.0001pt;
=09text-autospace:none;
=09font-size:12.0pt;
=09font-family:"Verdana",sans-serif;
=09color:black;}
span.EmailStyle24
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle25
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle26
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle27
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle28
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle29
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle30
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle31
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle32
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle33
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle34
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle35
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle36
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle37
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle38
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle39
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle40
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle41
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle42
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle43
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle44
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle45
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle46
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle47
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle48
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle49
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle50
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle51
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:#1F497D;}
span.EmailStyle52
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle53
=09{mso-style-type:personal-reply;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
.MsoChpDefault
=09{mso-style-type:export-only;
=09font-size:10.0pt;}
@page WordSection1
=09{size:612.0pt 792.0pt;
=09margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
=09{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang=3D"EN-AU" link=3D"blue" vlink=3D"purple">
<div class=3D"WordSection1">
<p class=3D"MsoNormal"><span lang=3D"EN-US">Hi,<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US">Recruitment is now open for Gr=
oup 8 of the popular DGAT
</span>Non-Alcoholic Fatty Liver Disease <span lang=3D"EN-US">study!<o:p><=
/o:p></span></p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoNormal">5 days/nights inpatient stay with just one follow u=
p, screening beginning next week Monday 19 September. Get in quick guys as=
 this study fills very quickly!<o:p></o:p></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center"><sp=
an style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;co=
lor:#351E56">If you are interested in the study below, please respond to t=
his email as we need to book you for a screening visit
 (medical check up).<o:p></o:p></span></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center"><sp=
an style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;co=
lor:#351E56">Please note we call from a
<u>private number.</u></span><u><span style=3D"font-size:11.0pt;font-famil=
y:&quot;Calibri&quot;,sans-serif;color:#1F497D"><o:p></o:p></span></u></p>=

<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center"><u>=
<span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif=
"><o:p><span style=3D"text-decoration:none">&nbsp;</span></o:p></span></u>=
</p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center"><b>=
<span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif=
;color:black">YOU NEED TO CALL/EMAIL TO MAKE AN APPOINTMENT. NO WALK-INS.<=
/span></b><b><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quo=
t;,sans-serif;color:#1F497D"><o:p></o:p></span></b></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center"><b>=
<span style=3D"font-size:14.0pt;font-family:&quot;Calibri&quot;,sans-serif=
;color:#E46C0A">WHEN YOU CALL, QUOTE &#8220;DGAT STUDY&#8221;<o:p></o:p></=
span></b></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center"><b>=
<span style=3D"font-size:14.0pt;font-family:&quot;Calibri&quot;,sans-serif=
">Screening from Monday 19<sup>th</sup> September
<o:p></o:p></span></b></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center"><b>=
<span style=3D"font-size:14.0pt;font-family:&quot;Calibri&quot;,sans-serif=
"><o:p>&nbsp;</o:p></span></b></p>
<p class=3D"MsoPlainText"><b><span style=3D"font-size:11.0pt;font-family:&=
quot;Calibri&quot;,sans-serif">204856:</span></b><span style=3D"font-size:=
11.0pt;font-family:&quot;Calibri&quot;,sans-serif">&nbsp;This study is inv=
estigating a drug that has been developed as a potential treatment
 for Non-Alcoholic Fatty Liver Disease (NAFLD).</span><span style=3D"color=
:#1F497D"><o:p></o:p></span></p>
<p class=3D"Default"><span style=3D"font-size:11.0pt;font-family:&quot;Cal=
ibri&quot;,sans-serif">Fat</span><span style=3D"font-size:11.0pt;font-fami=
ly:&quot;Arial&quot;,sans-serif">
</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,san=
s-serif">build up in the liver is responsible for liver disease which affe=
cts between 9% and 37% of the population in different parts of the world a=
nd is an increasing health burden to our society.
 In Australia, NAFLD is becoming an increasing problem in parallel with th=
e growing epidemic of obesity. The best treatment for NAFLD is diet and ex=
ercise, however too few people can maintain lifestyle changes to maintain =
meaningful changes to their health.
 NAFLD can lead to the more severe form called Nonalcoholic Steatohepatiti=
s (NASH) and ultimately to cirrhosis (scarring of liver), complete liver f=
ailure, or cancer. Currently there are no effective available treatments f=
or these conditions.
<o:p></o:p></span></p>
<p class=3D"Default"><span style=3D"font-size:11.0pt;font-family:&quot;Cal=
ibri&quot;,sans-serif">A central mediator in the transition from NAFLD to =
NASH is thought to be increased fat in the form of triglycerides in the li=
ver and other tissues. GSK3008356 works in a unique
 way by binding to and inhibiting a protein called DGAT1 which is a key pr=
otein involved in making triglycerides. It is hoped that GSK3008356 could =
be a better treatment option for those suffering from NAFLD and other rela=
ted diseases.</span><span style=3D"font-family:&quot;Calibri&quot;,sans-se=
rif"><o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"text-autospace:none"><span style=3D"font-s=
ize:12.0pt;color:black">&nbsp;</span><span style=3D"color:black">&nbsp;<o:=
p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"text-autospace:none"><b><span style=3D"col=
or:#0070C0"><a href=3D"http://clinicalstudies.com.au/wp-content/uploads/20=
16/09/PICF_v3_GSK-DGAT_Part-1_SD_15Aug2016.pdf">Please click here for more=
 information (Participant Information and Consent
 Form)</a><o:p></o:p></span></b></p>
<p class=3D"MsoNormal" style=3D"text-autospace:none"><span style=3D"color:=
#1F497D"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif;color:black">&nbsp;</span><b><span style=3D"fon=
t-family:&quot;Calibri&quot;,sans-serif;color:black">Volunteers required:
</span></b><span style=3D"font-family:&quot;Calibri&quot;,sans-serif;color=
:black"><o:p></o:p></span></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt"><span style=3D=
"font-family:Symbol;color:black">&middot;</span><span style=3D"font-size:7=
.0pt;font-family:&quot;Times New Roman&quot;,serif;color:black">&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span style=3D"color:black">Healthy Males <o:p></o:p></span></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt"><span style=3D=
"font-family:Symbol;color:black">&middot;</span><span style=3D"font-size:7=
.0pt;font-family:&quot;Times New Roman&quot;,serif;color:black">&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span style=3D"color:black">Aged 18 &#8211; 65 years <o:p></o:p></s=
pan></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt"><span style=3D=
"font-family:Symbol">&middot;</span><span style=3D"font-size:7.0pt;font-fa=
mily:&quot;Times New Roman&quot;,serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;
</span><b><span style=3D"color:black">BMI 19 &#8211; 25</span></b><span st=
yle=3D"color:black"> (Minimum weight 50 kg)</span>&nbsp;
<o:p></o:p></p>
<p class=3D"MsoNormal" style=3D"margin-left:36.0pt">Link to BMI calculator=
: <a href=3D"http://halls.md/body-mass-index/av.htm">
http://halls.md/body-mass-index/av.htm</a><o:p></o:p></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt"><span style=3D=
"font-family:Symbol;color:black">&middot;</span><span style=3D"font-size:7=
.0pt;font-family:&quot;Times New Roman&quot;,serif;color:black">&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span style=3D"color:black">Not taking any medications<o:p></o:p></=
span></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt"><span style=3D=
"font-family:Symbol;color:black">&middot;</span><span style=3D"font-size:7=
.0pt;font-family:&quot;Times New Roman&quot;,serif;color:black">&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span style=3D"color:black">You need to be able to eat the set menu=
 (it will contain dairy)<o:p></o:p></span></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt"><span style=3D=
"font-family:Symbol;color:black">&middot;</span><span style=3D"font-size:7=
.0pt;font-family:&quot;Times New Roman&quot;,serif;color:black">&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span style=3D"color:black">Not regular smokers and haven&#8217;t s=
moked in the last week (there is a nicotine test)<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:black">&nbsp;<o:p></o:p></span=
></p>
<p class=3D"MsoPlainText"><b><span style=3D"font-size:11.0pt;font-family:&=
quot;Calibri&quot;,sans-serif;color:black">Study Duration</span></b><span =
style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoPlainText" style=3D"margin-left:36.0pt;text-indent:-18.0pt"=
><span style=3D"font-family:Symbol">&middot;</span><span style=3D"font-siz=
e:7.0pt;font-family:&quot;Times New Roman&quot;,serif">&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,san=
s-serif;color:black">&nbsp;
</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,san=
s-serif">5 days/nights as an inpatient
</span><o:p></o:p></p>
<p class=3D"MsoPlainText" style=3D"margin-left:36.0pt;text-indent:-18.0pt"=
><span style=3D"font-family:Symbol">&middot;</span><span style=3D"font-siz=
e:7.0pt;font-family:&quot;Times New Roman&quot;,serif">&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,san=
s-serif">&nbsp;&nbsp;1 outpatient visit
</span><o:p></o:p></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style=3D"color:=
black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:black">Our Location</span><=
/b><span style=3D"color:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span =
style=3D"color:#1F497D"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:4.0pt;color:#1F497D"><o:p>=
&nbsp;</o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-left:36.85pt"><span style=3D"color:=
black">Centre for Clinical Studies
</span><span lang=3D"EN-US" style=3D"color:black">(AMREP Precinct Alfred H=
ospital)=20</span>
<span style=3D"color:black"><a href=3D"http://clinicalstudies.com.au/wp-co=
ntent/uploads/2014/02/AMREP-CCS-Access-MAP.pdf"><span style=3D"color:black=
">AMREP access map</span></a><o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-left:36.85pt"><span lang=3D"EN-US" =
style=3D"color:black">Level 5, 89 Commercial Road,
</span><span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-left:36.85pt"><span lang=3D"EN-US" =
style=3D"color:black">Melbourne, 3004</span><span style=3D"color:black">.<=
o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-left:36.85pt"><span style=3D"color:=
black">Click <a href=3D"https://maps.google.com.au/maps?q=3D89&#43;commerc=
ial&#43;road&#43;melbourne&#43;3004&amp;ie=3DUTF-8&amp;hq=3D&amp;hnear=3D0=
x6ad66822902afed9:0xca1cf794638a5956,85-89&#43;Commercial&#43;Rd,&#43;Melb=
ourne&#43;VIC&#43;3004&amp;gl=3Dau&amp;ei=3DrwD8UqTNL4GRkwX88YH4Aw&amp;ved=
=3D0CCYQ8gEwAA">
<span style=3D"color:black">here</span></a> for the <b>Google map</b>.<o:p=
></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:black">&nbsp;</span></b><sp=
an style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:black">Reimbursement</span>=
</b><span style=3D"color:black">:
</span><b><span style=3D"font-size:12.0pt;color:black">$1,600</span><span =
style=3D"color:black"><o:p></o:p></span></b></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#1F497D">&nbsp;</span></b><=
o:p></o:p></p>
<p class=3D"MsoNormal"><b>Study Schedule:<o:p></o:p></b></p>
<p class=3D"MsoNormal"><b>Cohort 8<o:p></o:p></b></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:4.0pt;color:#1F497D"><o=
:p>&nbsp;</o:p></span></b></p>
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" cellpadding=
=3D"0" width=3D"645" style=3D"width:484.0pt;margin-left:-1.15pt;border-col=
lapse:collapse">
<tbody>
<tr style=3D"height:21.05pt">
<td width=3D"215" nowrap=3D"" colspan=3D"2" style=3D"width:161.0pt;border:=
solid white 1.0pt;border-bottom:solid white 3.0pt;background:#DDD9C3;paddi=
ng:0cm 5.4pt 0cm 5.4pt;height:21.05pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">Study Day<o:p></o:p></span></b></p>
</td>
<td width=3D"212" nowrap=3D"" style=3D"width:158.7pt;border-top:solid whit=
e 1.0pt;border-left:none;border-bottom:solid white 3.0pt;border-right:soli=
d white 1.0pt;background:#DDD9C3;padding:0cm 5.4pt 0cm 5.4pt;height:21.05p=
t">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">Date<o:p></o:p></span></b></p>
</td>
<td width=3D"104" nowrap=3D"" style=3D"width:78.3pt;border-top:solid white=
 1.0pt;border-left:none;border-bottom:solid white 3.0pt;border-right:solid=
 white 1.0pt;background:#DDD9C3;padding:0cm 5.4pt 0cm 5.4pt;height:21.05pt=
">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">Time<o:p></o:p></span></b></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:solid white=
 1.0pt;border-left:none;border-bottom:solid white 3.0pt;border-right:solid=
 white 1.0pt;background:#DDD9C3;padding:0cm 5.4pt 0cm 5.4pt;height:21.05pt=
">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">Comments<o:p></o:p></span></b></p>
</td>
</tr>
<tr style=3D"height:25.75pt">
<td width=3D"84" nowrap=3D"" rowspan=3D"2" style=3D"width:62.95pt;border-t=
op:none;border-left:solid white 1.0pt;border-bottom:solid white 3.0pt;bord=
er-right:solid white 1.0pt;background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;=
height:25.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">On Study<o:p></o:p></span></b></p>
</td>
<td width=3D"131" nowrap=3D"" style=3D"width:98.05pt;border-top:none;borde=
r-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt=
;background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:25.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day -2=
<o:p></o:p></p>
</td>
<td width=3D"212" nowrap=3D"" style=3D"width:158.7pt;border-top:none;borde=
r-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt=
;background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:25.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Wednes=
day, 5 October 2016<o:p></o:p></p>
</td>
<td width=3D"104" nowrap=3D"" style=3D"width:78.3pt;border-top:none;border=
-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt;=
background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:25.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">14:00<=
o:p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt;=
background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:25.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Check-=
in<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:21.75pt">
<td width=3D"131" nowrap=3D"" style=3D"width:98.05pt;border-top:none;borde=
r-left:none;border-bottom:solid white 3.0pt;border-right:solid white 1.0pt=
;background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:21.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day 4<=
o:p></o:p></p>
</td>
<td width=3D"212" nowrap=3D"" style=3D"width:158.7pt;border-top:none;borde=
r-left:none;border-bottom:solid white 3.0pt;border-right:solid white 1.0pt=
;background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:21.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Monday=
, 10 October 2016<o:p></o:p></p>
</td>
<td width=3D"104" nowrap=3D"" style=3D"width:78.3pt;border-top:none;border=
-left:none;border-bottom:solid white 3.0pt;border-right:solid white 1.0pt;=
background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:21.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Before=
 12:00<o:p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid white 3.0pt;border-right:solid white 1.0pt;=
background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:21.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Check-=
out<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:25.65pt">
<td width=3D"84" nowrap=3D"" style=3D"width:62.95pt;border:solid white 1.0=
pt;border-top:none;background:#FABF8F;padding:0cm 5.4pt 0cm 5.4pt;height:2=
5.65pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">Final Visit<o:p></o:p></span></b></p>
</td>
<td width=3D"131" nowrap=3D"" style=3D"width:98.05pt;border-top:none;borde=
r-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt=
;background:#FABF8F;padding:0cm 5.4pt 0cm 5.4pt;height:25.65pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day 7<=
o:p></o:p></p>
</td>
<td width=3D"212" nowrap=3D"" style=3D"width:158.7pt;border-top:none;borde=
r-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt=
;background:#FABF8F;padding:0cm 5.4pt 0cm 5.4pt;height:25.65pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Thursd=
ay, 13 October 2016<o:p></o:p></p>
</td>
<td width=3D"104" nowrap=3D"" style=3D"width:78.3pt;border-top:none;border=
-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt;=
background:#FABF8F;padding:0cm 5.4pt 0cm 5.4pt;height:25.65pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">1 hour=
<o:p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt;=
background:#FABF8F;padding:0cm 5.4pt 0cm 5.4pt;height:25.65pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Outpat=
ient<o:p></o:p></p>
</td>
</tr>
</tbody>
</table>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal">To view our Participant Information Brochure please=
 <a href=3D"http://clinicalstudies.com.au/wp-content/uploads/2014/02/CCS-V=
olunteer-Brochure.pdf">
click here</a> and read more about our organisation and about clinical tri=
als generally.<o:p></o:p></p>
<p class=3D"MsoNormal"><span style=3D"color:red">&nbsp;</span><o:p></o:p><=
/p>
<p class=3D"MsoNormal">Please also visit our website at<span style=3D"colo=
r:#1F497D">
<a href=3D"http://www.clinicalstudies.com.au">www.clinicalstudies.com.au</=
a> </span>
<o:p></o:p></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#1F497D">&nbsp;</span></b><=
o:p></o:p></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#C00000">If you do not wish=
 to receive any further emails from us then please reply to this email wit=
h the word &#8216;unsubscribe&#8217; in the subject box.</span></b><o:p></=
o:p></p>
<p class=3D"MsoNormal">&nbsp;<o:p></o:p></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif">Thanking you again for your interest.<span sty=
le=3D"color:#1F497D">
</span></span><o:p></o:p></p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:12.0pt"><span style=3D"color=
:#1F497D">Kind Regards,<o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:20.0pt;font-family:&quo=
t;Edwardian Script ITC&quot;;color:#1F497D">Tina Cu<o:p></o:p></span></b><=
/p>
<p class=3D"MsoNormal" style=3D"mso-margin-top-alt:auto;mso-margin-bottom-=
alt:auto"><b><span style=3D"font-size:10.0pt;color:#1F497D">Tina Cu</span>=
</b><span style=3D"font-size:10.0pt;color:#1F497D">|<b> Recruitment Office=
r
</b>|&nbsp;<b>CCS AMREP</b> </span><span style=3D"font-size:10.0pt;color:b=
lack">|</span><b><span style=3D"font-size:10.0pt;color:#00B0F0"> Centre fo=
r Clinical Studies</span></b><span style=3D"font-size:10.0pt;color:#1F497D=
"> |&nbsp;<br>
Office: | Level 5 Burnet Institute | AMREP Precinct | 89 Commercial Road |=
&nbsp;Victoria 3004 | Australia<br>
Mail: | PO Box 6083, St Kilda Road Central, Melbourne, 8008, Victoria, Aus=
tralia |
<br>
Telephone:&nbsp;| T: 1800 243 733 |&nbsp;T: 9076 8936<br>
<a href=3D"mailto:t.cu@nucleusnetwork.com.au"><b><span lang=3D"FR" style=3D=
"color:#00B0F0">t.cu@nucleusnetwork.com.au</span></b></a></span><b><span l=
ang=3D"FR" style=3D"font-size:10.0pt;color:#00B0F0">&nbsp; &nbsp;&nbsp;</s=
pan></b><span style=3D"font-size:10.0pt;color:#1F497D"><a href=3D"http://w=
ww.nucleusnetwork.com.au/"><b><span style=3D"color:#00B0F0">www.clinicalst=
udies.com</span></b></a><a href=3D"http://www.nucleusnetwork.com.au/"><b><=
span style=3D"color:#00B0F0">.au</span></b></a><br>
<br>
<b><i>Nucleus Network, Australia's Clinical Research Centre, operates in a=
ssociation with Centre for Clinical Studies, Clinical Trials Consulting an=
d its network partners.<br>
</i></b><br>
<b>You can now follow us on <a href=3D"https://www.facebook.com/pages/Cent=
re-for-Clinical-Studies/199371513417842">
Facebook</a></b><br>
</span><b><i><span style=3D"font-size:10.0pt;color:green">Please consider =
the environment before printing this e-mail</span></i></b><b><i><span styl=
e=3D"font-size:10.0pt;color:#1F497D"><o:p></o:p></span></i></b></p>
</div>
<br clear=3D"both">
______________________________________________________________________<BR>=

This email has been scanned by the Symantec Email Security.cloud service.<=
BR>
For more information please visit http://www.symanteccloud.com<BR>
______________________________________________________________________<BR>=

</body>
</html>

--_000_FD1C4625A9476F49819B4449974CD12C1EC443PRNEX2010nucleusl_--
